KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Change in Accured Expenses (2016 - 2019)

Thermo Fisher Scientific filings provide 11 years of Change in Accured Expenses readings, the most recent being $38.0 million for Q4 2019.

  • On a quarterly basis, Change in Accured Expenses fell 75.8% to $38.0 million in Q4 2019 year-over-year; TTM through Dec 2019 was $210.0 million, a 600.0% increase, with the full-year FY2019 number at $210.0 million, up 600.0% from a year prior.
  • Change in Accured Expenses hit $38.0 million in Q4 2019 for Thermo Fisher Scientific, up from -$147.0 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $992.0 million in Q4 2017 to a low of -$471.0 million in Q1 2018.
  • Median Change in Accured Expenses over the past 5 years was $115.2 million (2015), compared with a mean of $80.0 million.
  • The widest YoY moves for Change in Accured Expenses: up 12019.44% in 2015, down 247.98% in 2015.
  • Thermo Fisher Scientific's Change in Accured Expenses stood at $436.3 million in 2015, then decreased by 16.89% to $362.6 million in 2016, then surged by 173.58% to $992.0 million in 2017, then tumbled by 84.17% to $157.0 million in 2018, then plummeted by 75.8% to $38.0 million in 2019.
  • The last three reported values for Change in Accured Expenses were $38.0 million (Q4 2019), -$147.0 million (Q3 2019), and $549.0 million (Q2 2019) per Business Quant data.